Study design

longitudil observatiol study s

Study time

2017.1-2020.4

Country

Japan

Object

patients with CaP who were treated with RARP. The inclusion criteria called for patients with localized CaP who fulfilled frailty screening, HRQOL, and LUTS questionires at baseline and 12 months after RARP.

Inclusion criteria

patients who did not provide complete responses to the G8, SF-8, or EPIC questionires.

Sample size

118

Topic classification

Special populations，QoL

Keypoint

Frailty was not significantly associated with the worsening of HRQOL, LUTS, and pad-free continence rates in patients treated with RARP.

Year